New technique to improve urinary control after prostate surgery
A New Vesicocervical Urethral Reconstruction Technique Improves Urinary Continence in Patients After Laparoscopic Radical Prostatectomy: a Single-center Randomized Controlled Trial
This study is testing a new surgery technique to see if it can help men regain better control over their urination after prostate cancer surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | N/A to 79 Years |
| Sex | Male |
| Sponsor | Suzhou Municipal Hospital Academic / other |
| Locations | 1 site (Suzhou, Jiangsu) |
| Trial ID | NCT06754488 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates a novel bladder neck urethral reconstruction technique aimed at enhancing early urinary continence in patients undergoing laparoscopic radical prostatectomy for prostate cancer. The study employs a randomized controlled design, dividing participants into four groups to assess the effectiveness of various reconstruction methods. By focusing on the preservation and reconstruction of urinary control structures, the trial seeks to address the significant issue of postoperative urinary incontinence, which affects many patients' quality of life. The outcomes will be evaluated based on improvements in urinary control following surgery.
Who should consider this trial
Good fit: Ideal candidates are men diagnosed with localized prostate cancer (clinical stage T1 and T2) who are scheduled for laparoscopic radical prostatectomy.
Not a fit: Patients with severe comorbidities, extensive metastasis, or a history of urinary incontinence may not benefit from this study.
Why it matters
Potential benefit: If successful, this technique could significantly reduce urinary incontinence in patients after prostate surgery, improving their quality of life.
How similar studies have performed: While various techniques have been explored for improving urinary control post-surgery, this specific approach is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: (1) Preoperative needle biopsy confirmed prostate cancer; (2) The clinical stage is T1 and T2 Exclusion Criteria: (1) Diseases that significantly increase the risk of surgery or anesthesia, such as severe cardiovascular diseases, respiratory diseases, and coagulation disorders. (2) Patients with extensive bone metastasis or metastases to other organs (3) patients with a history of urinary incontinence and transurethral resection of the prostate. (4) Tumor invasion of bladder neck.
Where this trial is running
Suzhou, Jiangsu
- Suzhou Municipal Hospital — Suzhou, Jiangsu, China (Recruiting)
Study contacts
- Study coordinator: Tengyue Zeng, doctor
- Email: zty19881201@163.com
- Phone: 86-18351898896
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.